Literature DB >> 7868954

Epidemiologic characteristics of leprosy reactions.

D M Scollard1, T Smith, L Bhoopat, C Theetranont, S Rangdaeng, D M Morens.   

Abstract

An 8-year prospective study of a cohort of 176 newly diagnosed leprosy patients was conducted to examine the possible influence of age, sex, multidrug therapy (MDT), and duration of illness on the risk of either type 1 or type 2 reactions. Patients were enrolled over a 5-year period (1984-1989) and followed for a minimum of 3 years. All reactions studied were severe enough to warrant hospital admission. Overall, 45% of this cohort developed a reaction; 32% of patients considered at risk developed type 1 reactions, and 37% of patients considered at risk developed type 2 reactions. Despite the predominance of men among the leprosy patients, type 1 reactions occurred with significantly greater frequency in women, and did not appear to be influenced by age of onset of leprosy. Individuals experiencing one type 1 reaction were not likely to experience a recurrence, suggesting that the immunologic mechanisms of this reaction may be limited or regulated by genetic or immunologic factors. Type 2 reactions, on the other hand, occurred with equal frequency in both males and females, but were highly associated with onset of leprosy in the second decade of life. Individuals who experienced type 2 reactions often had one or more recurrence of the reaction. No increased risk was seen for either reaction with longer duration of leprosy or longer duration of treatment. The mechanisms by which these differences relate to the pathogenesis of leprosy reactions remains unclear, but future studies of clinical and immunological parameters of leprosy reactions may benefit from stratification of data by gender and age of onset of leprosy in addition to the routine grouping of results by leprosy classification.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7868954

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  24 in total

1.  Risk factors for leprosy reactions in three endemic countries.

Authors:  David M Scollard; Celina M T Martelli; Mariane M A Stefani; Maria de Fatima Maroja; Laarni Villahermosa; Fe Pardillo; Krishna B Tamang
Journal:  Am J Trop Med Hyg       Date:  2014-12-01       Impact factor: 2.345

2.  Lupus and leprosy: beyond the coincidence.

Authors:  F M Ribeiro; V E Gomez; E M N Albuquerque; E M Klumb; Y Shoenfeld
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 3.  The continuing challenges of leprosy.

Authors:  D M Scollard; L B Adams; T P Gillis; J L Krahenbuhl; R W Truman; D L Williams
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

4.  Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy.

Authors:  Megan S Inkeles; Rosane Mb Teles; Delila Pouldar; Priscila R Andrade; Cressida A Madigan; David Lopez; Mike Ambrose; Mahdad Noursadeghi; Euzenir N Sarno; Thomas H Rea; Maria T Ochoa; M Luisa Iruela-Arispe; William R Swindell; Tom Hm Ottenhoff; Annemieke Geluk; Barry R Bloom; Matteo Pellegrini; Robert L Modlin
Journal:  JCI Insight       Date:  2016-09-22

5.  The Burden of Helminth Coinfections and Micronutrient Deficiencies in Patients with and without Leprosy Reactions: A Pilot Study in Minas Gerais, Brazil.

Authors:  Jessica K Fairley; Jose A Ferreira; Ana Laura Grossi de Oliveira; Thelma de Filippis; Maria Aparecida de Faria Grossi; Laura Pinheiro Chaves; Luiza Navarro Caldeira; Paola Souza Dos Santos; Rafaella Rodrigues Costa; Maria Cavallieri Diniz; Carolina Soares Duarte; Luiz Alberto Bomjardim Pôrto; Parminder S Suchdev; Deborah Aparecida Negrão-Corrêa; Fernanda do Carmo Magalhães; João Marcelo Peixoto Moreira; Adelino de Melo Freire Júnior; Mariana Costa Cerqueira; Uriel Kitron; Sandra Lyon
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

6.  Evaluation of cellular phenotypes implicated in immunopathogenesis and monitoring immune reconstitution inflammatory syndrome in HIV/leprosy cases.

Authors:  Carmem Beatriz Wagner Giacoia-Gripp; Anna Maria Sales; José Augusto da Costa Nery; Joanna Reis Santos-Oliveira; Ariane Leite de Oliveira; Euzenir Nunes Sarno; Mariza Gonçalves Morgado
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

7.  Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report.

Authors:  Mariane M Stefani; Jackeline G Guerra; Ana Lucia M Sousa; Mauricio B Costa; Maria Leide W Oliveira; Celina T Martelli; David M Scollard
Journal:  BMC Infect Dis       Date:  2009-05-27       Impact factor: 3.090

Review 8.  Understanding the type 1 reactional state for early diagnosis and treatment: a way to avoid disability in leprosy.

Authors:  José Augusto da Costa Nery; Fred Bernardes Filho; Juliana Quintanilha; Alice Miranda Machado; Soraya de Souza Chantre Oliveira; Anna Maria Sales
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

Review 9.  A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction.

Authors:  Carlijn G N Voorend; Erik B Post
Journal:  PLoS Negl Trop Dis       Date:  2013-10-03

10.  Leprosy Reaction in Thai Population: A 20-Year Retrospective Study.

Authors:  Poonkiat Suchonwanit; Siripich Triamchaisri; Sanchawan Wittayakornrerk; Ploysyne Rattanakaemakorn
Journal:  Dermatol Res Pract       Date:  2015-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.